Long term follow up of Hemophilia A patients who previously showed complete or partial success in immune tolerance induction therapy with a single pdFVIII/VWF product (Fanhdi)
Phase of Trial: Phase IV
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Sponsors Grifols
- 30 Mar 2016 Status changed from active, no longer recruiting to completed.
- 25 Apr 2015 Status changed from recruiting to active, no longer recruiting, as reported by United Kingdom Clinical Research Network record.
- 11 Dec 2014 New trial record